Views provided by UsageCounts
pmid: 3046216
handle: 2434/206135
GnRH agonists, synthetic peptide analogs of GnRH, desensitize pituitary receptors for the native molecule, thus causing reversible hypogonadotropic hypogonadism. Numerous clinical studies have suggested that these compounds are efficacious in the treatment of endometriosis, but it is not clear whether they are superior to the other drugs used in treatment of this disease. The frequency of recurrence of pain symptoms at the end of treatment is high and the data on recovery of fertility are conflicting. Long-term administration of GnRH agonists is a safe and well tolerated treatment but its role in the management of endometriosis is still not well defined.
Clinical Trials as Topic, Animals ; Humans ; Pituitary Hormone-Releasing Hormones ; Clinical Trials as Topic ; Endometriosis ; Female, Endometriosis, Animals, Humans, Female, Pituitary Hormone-Releasing Hormones
Clinical Trials as Topic, Animals ; Humans ; Pituitary Hormone-Releasing Hormones ; Clinical Trials as Topic ; Endometriosis ; Female, Endometriosis, Animals, Humans, Female, Pituitary Hormone-Releasing Hormones
| citations The total number of citations received by all articles of the researcher of interest. | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 34 |

Views provided by UsageCounts